Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kit Shaw"'
Autor:
Terese C. Hammond, Marco A. Purbhoo, Sapana Kadel, Jerome Ritz, Sarah Nikiforow, Heather Daley, Kit Shaw, Koen van Besien, Alexandra Gomez-Arteaga, Don Stevens, Waldo Ortuzar, Xavier Michelet, Rachel Smith, Darrian Moskowitz, Reed Masakayan, Burcu Yigit, Shannon Boi, Kah Teong Soh, John Chamberland, Xin Song, Yu Qin, Ilya Mishchenko, Maurice Kirby, Valeriia Nasonenko, Alexa Buffa, Jennifer S. Buell, Dhan Chand, Marc van Dijk, Justin Stebbing, Mark A. Exley
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-15 (2024)
Abstract Invariant natural killer T (iNKT) cells, a unique T cell population, lend themselves for use as adoptive therapy due to diverse roles in orchestrating immune responses. Originally developed for use in cancer, agenT-797 is a donor-unrestricte
Externí odkaz:
https://doaj.org/article/d15d9c3789204f0f9cbf46c7c032881d
Autor:
Matthew J. Frigault, Michael R. Bishop, Jacalyn Rosenblatt, Elizabeth K. O’Donnell, Noopur Raje, Daniella Cook, Andrew J. Yee, Emma Logan, David E. Avigan, Andrzej Jakubowiak, Kit Shaw, Heather Daley, Sarah Nikiforow, Faith Griffin, Christine Cornwell, Angela Shen, Christopher Heery, Marcela V. Maus
Publikováno v:
Blood Advances. 7:768-777
Relapsed and refractory multiple myeloma (RRMM) is a plasma cell neoplasm defined by progressively refractory disease necessitating chronic and increasingly intensive therapy. Despite recent advances, limited treatment options exist for RRMM. This si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae1a9636028e8421071dae6dd97a1f3c
https://doi.org/10.1182/bloodadvances.2022007210
https://doi.org/10.1182/bloodadvances.2022007210
Autor:
Ula Jurkunas, Jia Yin, Lynette Johns, Sanming Li, Helene Negre, Kit Shaw, Lassana Samarakoon, Allison Ayala, Ahmad Kheirkhah, Kishore Katikireddy, Alex Gauthier, Stephan Ong Tone, Stacey Ellender, Diego Hernandez Rodriguez, Heather Daley, Reza Dana, Jerome Ritz, Myriam Armant
The authors have requested that this preprint be removed from Research Square.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7cb9f111a7d817e469391ff9625d590
https://doi.org/10.21203/rs.3.rs-1630868/v1
https://doi.org/10.21203/rs.3.rs-1630868/v1
Autor:
Erica B, Esrick, Leslie E, Lehmann, Alessandra, Biffi, Maureen, Achebe, Christian, Brendel, Marioara F, Ciuculescu, Heather, Daley, Brenda, MacKinnon, Emily, Morris, Amy, Federico, Daniela, Abriss, Kari, Boardman, Radia, Khelladi, Kit, Shaw, Helene, Negre, Olivier, Negre, Sarah, Nikiforow, Jerome, Ritz, Sung-Yun, Pai, Wendy B, London, Colleen, Dansereau, Matthew M, Heeney, Myriam, Armant, John P, Manis, David A, Williams
Publikováno v:
The New England journal of medicine. 384(3)
Sickle cell disease is characterized by hemolytic anemia, pain, and progressive organ damage. A high level of erythrocyte fetal hemoglobin (HbF) comprising α- and γ-globins may ameliorate these manifestations by mitigating sickle hemoglobin polymer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a54e613c2a9b45852cee621477397c3b
https://pubmed.ncbi.nlm.nih.gov/33471981
https://pubmed.ncbi.nlm.nih.gov/33471981